Niagen Bioscience, Inc. (NAGE) Profit Margins
Over the twelve months to 2026-06-30, Niagen Bioscience, Inc. (NAGE) had gross margin 64.2%, operating margin 8.2%, net margin 12.4%, free cash flow margin 4.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NAGENiagen Bioscience, Inc.Follow NAGE — free
—
Price chart with a free account
- Market cap
- 192.3M
- P/E TTM
- 13.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 50.9% | 55.7% | 59.5% | 61.5% | 59.4% | 60.8% | 61.8% | 64.3% | 64.2% | |
| Operating margin | -105.1% | -67.6% | -33.5% | -40.1% | -25.9% | -6.7% | 7.8% | 12.6% | 8.2% | |
| Net margin | -105.6% | -69.4% | -33.6% | -40.2% | -23.0% | -5.9% | 8.6% | 13.4% | 12.4% | |
| FCF margin | -70.4% | -45.8% | — | — | -21.4% | 8.3% | 12.0% | 10.2% | 4.4% |
USD millions · SEC XBRL
Niagen Bioscience, Inc. — questions
- What is Niagen Bioscience, Inc.'s gross margin?
- 64.2% over the twelve months to 2026-06-30.
- What is Niagen Bioscience, Inc.'s operating margin?
- 8.2% over the twelve months to 2026-06-30.
- What is Niagen Bioscience, Inc.'s net profit margin?
- 12.4% over the twelve months to 2026-06-30.
Every figure on this page comes from Niagen Bioscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.